The molecular mechanisms of alkylating agent-related acute myeloid leukaemia

Published: June 16, 2009
Abstract Views: 171
PDF: 1168
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Alkylating chemotherapy agents are used with considerable success to treat numerous human malignancies, including lung cancer, breast cancer, Hodgkin lymphoma and multiple myeloma. Alkylating agents encompass a broad range of structurally diverse agents that includes nitrogen mustards, methylating agents, platinating agents and nitrosoureas.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Allan, J. M. (2009). The molecular mechanisms of alkylating agent-related acute myeloid leukaemia. Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.599